Results 151 to 160 of about 48,541 (237)

Application of carbonic anhydrase IX-targeted radiopharmaceuticals in the diagnosis and treatment of clear cell renal cell carcinoma (Review). [PDF]

Oncol Lett
Wang M, Li Y, Yang W, Liu B.
europepmc   +1 more source

PET Imaging in Alzheimer Disease in the Era of Antiamyloid Therapy in the United States: Clinical Utility, Quantification, and Policy Landscape. [PDF]

J Nucl Med Technol
Skyles T, Bouchal SM, Giarratana A, Wengler J, Hart I, Greig E, Singh H, Huang SS, Martinez F, Nguyen B, Shin CH, Yang M, Parent E, Robb WH, Franceschi AM, Burkett B, Johnson D, Koran ME.   +17 more
europepmc   +1 more source

Tumour Microenvironment-Informed Radiotheranostics: Why and How Nuclear Medicine Could Advance Precision Oncology in the Decade Ahead. [PDF]

Pharmaceuticals (Basel)
Pandya K, Lin Z, Wadsak M, Wang J, Shi K, Seifert R.   +5 more
europepmc   +1 more source

Availability of Radiopharmaceuticals and Imaging Equipment in English-Speaking African Countries. [PDF]

J Nucl Med Technol
Mosima LS, Manicum AE, Summers B.
europepmc   +1 more source

How Regulation 536/2014 Is Changing Academic Research with Therapeutic Radiopharmaceuticals: A Local Experience. [PDF]

Pharmaceuticals (Basel)
Di Iorio V, Boschi S, Brugugnoli E, Sansovini M, Matteucci F, Masini C, Monti M.   +6 more
europepmc   +1 more source

Fluorination augments tumor engagement and antitumor immunity of a D-peptide-based radiotheranostic agent for combinatorial immune checkpoint blockade therapy. [PDF]

J Immunother Cancer
Zhang S, Liu C, Lu Q, Liu W, Wu J, Liu J, Tong L, Zhao K, Hu Q, Chen X, Li L, Song X, Wang F, Dai D, Wang R, Hu K.   +15 more
europepmc   +1 more source

Synthesis, Radiochemical Characterization, and Biodistribution of a ¹⁸⁸Re Analogue of [¹³¹I]mIBG in a Neuroblastoma Xenograft Model. [PDF]

J Labelled Comp Radiopharm
Sakhare N, Kumar D, Das S, Mitra A, Mirapurkar S, Rani G, Sheela M, Chirayil V, Mohanty B, Mathur A, Mallia MB, Chaudhari P.   +11 more
europepmc   +1 more source

Beyond discovery: are we understanding PET tracers as fast as we invent them? a critical review. [PDF]

EJNMMI Res
Ibrahim EA.
europepmc   +1 more source

Therapeutic Applications of Fibroblast Activation Protein (FAP)-Binding Radiopharmaceuticals: Review of Opportunities and Challenges. [PDF]

Cancers (Basel)
Maes J, Pôlet B, Kleynhans J, Van Herpe F, Goffin K, Dekervel J, Nafteux P, Topal B, Cleeren F, Deroose CM.   +9 more
europepmc   +1 more source

Using advanced cell models for targeted radionuclide therapy evaluation: increased efficacy in 3D versus 2D. [PDF]

EJNMMI Res
Klomp MJ, Erkens SE, van den Brink L, van Weerden WM, Dalm SU.   +4 more
europepmc   +1 more source